However, UnitedHealth Group and Amedisys allege the lawsuit essentially ignores the companies' proposed divestiture package. The company didn’t identify which locations would be sold ...

Amedisys has a 1-year low of $82.15 and a 1-year high of $98.95. The company has a market cap of $3.03 billion, a PE ratio of 36.71, a price-to-earnings-growth ratio of 1.82 and a beta of 0.73.

UnitedHealth Group says the Justice Department’s antitrust challenge to its proposed $3.3 billion purchase of Amedisys is wrong on the merits and threatens to deprive consumers of benefits from ...

Two whistleblowers have adequately alleged that Amedisys Inc. violated the False Claims Act by improperly billing Medicare and other federal health-care programs for home health services, a New York ...

MD Pediatrix Medical Group, Inc.

BKDT Brookdale Senior Living Inc.

UnitedHealth Group and Amedisys denied those allegations in their response filing Friday. In 2022, the government unsuccessfully sued to block Optum’s $13 billion acquisition of Change ...